Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Select Medical Holdings (SEM) Shares Repurchased (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Shares Repurchased for 8 consecutive years, with $542000.0 as the latest value for Q4 2025.

  • For Q4 2025, Shares Repurchased fell 97.29% year-over-year to $542000.0; the TTM value through Mar 2026 reached $88.7 million, up 79.92%, while the annual FY2025 figure was $100.1 million, 164.02% up from the prior year.
  • Shares Repurchased hit $542000.0 in Q4 2025 for Select Medical Holdings, down from $2.0 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $126.9 million in Q2 2022 and bottomed at $542000.0 in Q4 2025.
  • Average Shares Repurchased over 5 years is $25.0 million, with a median of $11.4 million recorded in 2025.
  • Year-over-year, Shares Repurchased skyrocketed 7784.91% in 2022 and then crashed 98.81% in 2023.
  • Select Medical Holdings' Shares Repurchased stood at $13.4 million in 2021, then crashed by 85.74% to $1.9 million in 2022, then fell by 10.71% to $1.7 million in 2023, then skyrocketed by 1069.16% to $20.0 million in 2024, then crashed by 97.29% to $542000.0 in 2025.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at $542000.0, $2.0 million, and $86.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.